Organogenesis Holdings Inc. Soared
Thu, Jan 14, 2021 at 05:33 PM
Organogenesis Holdings Inc. (ORGO:NASDAQ) soared at $9.49, representing a gain of 29.3%. On Wed 13 Jan 21, ORGO:NASDAQ touched a New 2-Week Intraday Low of $7.22. The stock appeared on our News Catalysts scanner on Thu 14 Jan 21 at 12:06 PM in the 'BIOTECH' category. From Wed 30 Dec 20, the stock recorded 44.44% Up Days and 50.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Organogenesis Holdings Inc. (ORGO:NASDAQ)
Organogenesis Holdings Inc, formerly Avista Healthcare Public Acquisition Corp is a regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets.
Top 10 Gainers:
- Lexicon Pharmaceuticals, Inc. (LXRX:NASDAQ), 105.36%
- VCA Inc. (WOOF:NASDAQ), 63.33%
- 3D Systems Corporation (DDD:NYSE), 36.21%
- Senseonics Holdings, Inc. (SENS:NYSEMKT), 34.89%
- DPW Holdings, Inc. (DPW:NYSEMKT), 33.65%
- CPS Technologies Corporation (CPSH:NASDAQ), 32.98%
- Acacia Communications, Inc. (ACIA:NASDAQ), 31.45%
- AeroVironment, Inc. (AVAV:NASDAQ), 30.28%
- Organogenesis Holdings Inc. (ORGO:NASDAQ), 29.29%
- Bicycle Therapeutics plc (BCYC:NASDAQ), 28.46%